1. The assay and clinical significance of serum thymidine kinase 1 in patients with colorectal carcinoma
   Y. Zhang et al, 2015, European Surgery CrossRef
2. Diagnostic value of soluble interleukin-2 receptor in patients with lymphoproliferative diseases
   N. K. Parilova et al, 2016, Onkologiya. Zhurnal imeni P.A.Gertsena CrossRef
3. Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
   Vilde D. Haakensen et al, 2020, International Journal of Cancer CrossRef
4. Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
   Yujing Fang et al, 2023, Discover Oncology CrossRef
5. STK1p As a Prognostic Biomarker for Overall Survival in non-small-cell Lung carcinoma, Based on real-world Data
   Zhenxin Wang et al, 2021, Future Science OA CrossRef
6. A meta‑analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
   Li Dang et al, 2020, Molecular and Clinical Oncology CrossRef
7. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people
   Yu Wang et al, 2016, Cancer Biomarkers CrossRef
8. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
   Jianjun Wang et al, 2017, Tumor Biology CrossRef
9. Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
   Luc Cabel et al, 2020, Breast Cancer Research CrossRef
10. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
    Kiran Kumar Jagarlamudi et al, 2015, BMC Cancer CrossRef
11. Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
    A. Matikas et al, 2021, ESMO Open CrossRef
12. Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery
    Xiangbin Wang et al, 2023, Journal of Immunology Research CrossRef
13. Non-Viral Deoxyribonucleoside Kinases – Diversity and Practical Use
    Louise Slot Christiansen et al, 2015, Journal of Genetics and Genomics CrossRef
14. Concentration of human thymidine kinase 1 discover invisible malignant human tumours
    Ji Zhou et al, 2022, European Journal of Cell Biology CrossRef
15. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer
    Klaus Felix et al, 2018, Pancreas CrossRef
16. Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
    Zhiwu Wang et al, 2020, Bioscience Reports CrossRef